Business Insider: A longevity researcher started taking testosterone in his 50s. He says there are 4 things everyone should know before considering TRT

In 2020, longevity researcher and OptiSpan CEO Matt Kaeberlein began noticing the classic signs of low testosterone, declining energy, a significant drop in libido, and difficulty changing his body composition despite consistent strength training and a balanced diet.

After getting his levels tested and navigating a trial-and-error process with medications and supplements, Kaeberlein found a treatment plan that worked. Now, he's sharing the 4 things everyone should know before considering TRT.

Read the full article here